Differentiation of Foot-and-Mouth Disease-Infected pigs from Vaccinated Pigs Using Antibody-Detecting Sandwich ELISA by Chen, T.H. et al.
FULL PAPER Virology
Differentiation of Foot-and-Mouth Disease-Infected Pigs from Vaccinated Pigs Using 
Antibody-Detecting Sandwich ELISA
Tsu-Han CHEN1,2), Fan LEE1,2), Yeou-Liang LIN1), Aldo DEKKER4), Wen-Bin CHUNG5), Chu-Hsiang PAN1), 
Ming-Hwa JONG1), Chin-Cheng HUANG1), Ming-Chang LEE2,6) and Hsiang-Jung TSAI2,3)*
1)Division of Hog Cholera Research, Animal Health Research Institute, 376 Chung-Cheng Road, Tamsui, New Taipei City 25158, 
2)Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, 1, Section 4 Roosevelt Road, 
Taipei 10617, 3)Zoonoses Research Center, School of Veterinary Medicine, National Taiwan University, 1, Section 4 Roosevelt Road, 
Taipei 10617, Taiwan, 4)Central Veterinary Institute, P. O. Box 65, 8220 AB Lelystad, The Netherlands, 5)Department of Veterinary 
Medicine, National Pingtung University of Science and Technology, 1 Shuefu Road, Neipu, Pingtung County 91201 and 
6)Division of Animal Medicine, Animal Technology Institute Taiwan, P.O. Box 23, Chunan, Miaoli 35053, Taiwan
(Received 19 August 2010/Accepted 21 March 2011/Published online in J-STAGE 4 April 2011)
ABSTRACT. The presence of serum antibodies for nonstructural proteins of the foot-and-mouth disease virus (FMDV) can differentiate
FMDV-infected animals from vaccinated animals.  In this study, a sandwich ELISA was developed for rapid detection of the foot-and-
mouth disease (FMD) antibodies; it was based on an Escherichia coli-expressed, highly conserved region of the 3ABC nonstructural pro-
tein of the FMDV O/TW/99 strain and a monoclonal antibody derived from the expressed protein.  The diagnostic sensitivity of the assay
was 98.4%, and the diagnostic specificity was 100% for naïve and vaccinated pigs; the detection ability of the assay was comparable
those of the PrioCHECK and UBI kits.  There was 97.5, 93.4 and 66.6% agreement between the results obtained from our ELISA and
those obtained from the PrioCHECK, UBI and CHEKIT kits, respectively.  The kappa statistics were 0.95, 0.87 and 0.37, respectively.
Moreover, antibodies for nonstructural proteins of the serotypes A, C, Asia 1, SAT 1, SAT 2 and SAT 3 were also detected in bovine
sera.  Furthermore, the absence of cross-reactions generated by different antibody titers against the swine vesicular disease virus and
vesicular stomatitis virus (VSV) was also highlighted in this assay’s specificity.
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Foot-and-mouth disease (FMD) is one of the most conta-
gious diseases amongst artiodactyla (cloven-hoofed mam-
mals) and thus can have economically devastating effects
[27].  Foot-and-mouth disease virus (FMDV) belongs to the
Aphthovirus genus in the family Picornaviridae.  It is a non-
enveloped virus with a positive-sense, single-stranded RNA
genome that is 8.5 kb in length and is immediately translated
into a polyprotein upon entry of the virus into a host cell.
This polyprotein is posttranslationally cleaved to yield 12
mature proteins [30, 33].  The 12 proteins comprise, from 5’
to 3’, a set of four structural capsid proteins (1A, 1B, 1C and
1D, also known as VP4, VP2, VP3 and VP1, respectively)
and eight nonstructural proteins (NSPs; Lpro, 2A, 2B, 2C,
3A, 3B, 3Cpro and 3Dpol) [31].  The structural proteins
(SPs) 1A to 1D assemble to form the capsid of the virion.
With the exception of 1A, they are the first line of contact
between the host cell and the virus.  The interaction between
the biological systems occurs specically between the capsid
protein VP1, the Arginine-Glycine-Aspartic acid (RGD)-
dependent integrins and cell surface heparan sulfate (HS)
glycosaminoglycan receptors [21].  The NSPs are involved
in RNA replication, polyprotein processing, protease cleav-
age, inhibition of MHC class I expression, stimulation of
VPg uridylylation, increasing membrane permeability and
function of the early secretory pathway [16, 20, 28].  The
high mutation rates [2, 14] and population bottlenecks that
occur during the transmission of RNA viruses such as
FMDV [15] account for the high genetic and antigenic vari-
ability of these viruses.  This genetic variability is translated
into the existence of seven immunologically diverse sero-
types distributed around the world (southern African types
[SAT] 1 to 3 and Asia 1, A, O and C), which have varied
degrees of selective genetic variability [18, 22, 38].  Infec-
tion with one serotype does not confer protection against
another.  Globally, FMDV serotypes O and A are the most
prevalent.
In 1997, an epidemic of FMD serotype O occurred in Tai-
wan and caused great economic losses (estimated at over
US$ 1.6 billion) due to control measures and trade regula-
tions [40].  The FMDV strain referred to as O/TW/1997 is a
prototype of a porcinophilic strain that only infects swine
[40].  The deletion at codons 93–102 within the 3A non-
structural protein region of the strain restricts viral replica-
tion in bovine epithelial cells in vitro [3].
In 1999, another FMD strain was discovered in subclini-
cally infected cattle on Kinmen Island in Taiwan.  This
strain, O/TW/2/1999 (PanAsia strain), differed from O/TW/
1997 in that it had a full-length 3A nonstructural protein that
gave the virus the capability to infect cattle [19].  In
response to the FMD outbreak, the Taiwanese government
immediately took quarantine measures by serologically
screening animals, humanely culling infected animals and
* CORRESPONDENCE TO: TSAI, H.-J., Zoonoses Research Center,
School of Veterinary Medicine, National Taiwan University, 1,
Section 4 Roosevelt Road, Taipei 10617, Taiwan.
   e-mail: tsaihj@ntu.edu.tw
T.-H. CHEN ET AL.978disposing of the carcasses.
In addition, the government carried out precautionary
screenings of farms suspected of FMDV infection to prevent
the spread of FMDV.
In an attempt to eliminate FMD from Taiwan, systematic
compulsory vaccination accompanied by serological sur-
veys was implemented to ensure the decrease in residual
viral activity.  Since antibodies to FMDV NSPs are consid-
ered to be present only in infected animals, the antibodies
can be used to discriminate infected from vaccinated ani-
mals.  Moreover, since the NSPs are relatively conserved
among different serotypes, the detection of anti-NSP anti-
bodies has an additional advantage of serotypes indepen-
dence [11, 12].  During the last decade, the use of
immunoenzymatic tests based on the detection of antibodies
to NSPs to assess viral circulation in susceptible populations
has been extensively studied and has allowed for a “vaccina-
tion to live” policy, and this approach can be supported by
testing vaccinated animals for the presence of antibodies to
certain NSPs of FMDV, which are induced by infection with
the virus, but not by vaccination with purified FMD vac-
cines [5, 29].  Many assay technologies, such as the latex
bead agglutination test [37], enzyme-linked immunoelec-
trotransfer blotting [4], enzyme-linked immunosorbent
assay [1, 5, 9, 11, 13, 19, 23, 25, 34–36], multiplexed
Luminex assay [12] and chromatographic strip assay [8]
have been employed, and several NSPs have been expressed
or synthesized artificially for these assays.
The sensitivity results of previous chromatographic strip
assays differed from those of commercially available kits
testing the prokaryotic expression system.  The performance
of the strip assay was comparable to that of two commercial
ELISA kits, Ceditest FMDV-NS and UBI FMDV NS EIA,
and was better than that of CHEKIT FMD-3ABC po [8].
For this reason, we developed a recombinant protein mono-
clonal antibody sandwich ELISA for FMDV-NSP that was
similar to the CHEKIT kit.  We have modified this study
design to improve the diagnostic sensitivity and diagnostic
specificity, and to provide a safer method, which used
recombinant protein instead of virus, for detecting anti-NSP
antibodies.  The aim of this study was to develop a sandwich
ELISA to detect serum antibodies against the FMDV 3ABC
core motif.  In this study, a monoclonal antibody (mAb)
against the 3ABC recombinant protein that was able to react
to serotype-specific antiserum against seven serotypes of
FMDV was produced.  A sandwich ELISA was developed
using the mAb to bind the 3ABC recombinant protein and
indirectly capture anti-FMDV antibodies in the serum sam-
ple.  The ELISA was shown to have higher sensitivity than
a commercially available ELISA kit based on the same
recombinant protein.
MATERIALS AND METHODS
Sera: To investigate the sensitivity of the tests, two
groups of 62 FMD-infected swine were evaluated according
to their sera.  Eight-week-old pigs were intradermally
infected with 0.5 ml of a 105 50% tissue culture infective
dose (TCID50/500 µl) of the FMDV O/TW/97 strain at the
heel bulb of the foot in level three biosafety facilities.  Thirty
infected sera were collected on the 28th day postinfection
(dpi), and 32 infected sera (positive sera) were collected on
the 14th dpi to determine the sensitivity.  In addition, 255
sera from naïve pigs and 165 sera from vaccinated pigs were
used to determine the specificity.  The 255 swine sera
included 96 sera collected from specific pathogen-free
(SPF) pigs and 159 sera collected from commercial pigs in
Taiwan before the 1997 outbreak.  The 165 swine sera were
collected from 165 noninfected pigs that had been vacci-
nated twice with the commercial FMD serotype O vaccine
(Professor W. B. Chung, National Pingtung University of
Science and Technology).  The swine sera were used to
evaluate the sandwich ELISA for possible serological cross-
reactivity between FMDV and swine vesicular disease virus
(SVDV) and vesicular stomatitis virus (VSV) to detect anti-
bodies against other FMDV serotypes.  In addition, six anti-
sera against the SVDV UKG/27/72 strain (EU SVD
reference serum batch 2002) and six bovine antisera against
FMDV serotypes A, C, Asia 1, SAT 1, SAT 2 and SAT 3
were purchased from the Institute for Animal Health, Pir-
bright, United Kingdom.  Three antisera against the New
Jersey and Indiana strains of VSV were purchased from the
National Veterinary Services Laboratories, United States of
America.  Fetal calf serum (FCS; HyClone) and normal
bovine serum were used for negative controls.  Only phos-
phate buffered saline (PBS; pH 7.4) buffer was added to the
blank.
To compare the sensitivity and specificity of the sand-
wich ELISA with those of three commercial ELISA kits, a
serum panel containing 320 swine sera from 32 SPF pigs
was purchased from Animal Technology Institute Taiwan
and experimentally infected with the FMDV O/TW/97
strain.  The sera in the panel were sampled at 0, 2, 4, 6, 8, 10,
14, 21, 28 and 34 dpi.
Convalescent swine sera from pigs experimentally
infected with the FMDV O/TW/97 strain or the O/TW/99
strain, with a VNT titer of 1:256 and 1:512, respectively,
were used as the positive control sera for the sandwich
ELISA.  An SPF swine serum was tested using western blot-
ting and was used as the negative control for the sandwich
ELISA.
Virus neutralization test (VNT): The sera collected from
experimentally infected pigs were tested using the VNT as
previously described [39].  Antibody titers were expressed
as the reciprocal of the final dilution of serum in the serum/
virus mixture that neutralized an estimated 100 TCID50 of
virus at the 50% end-point.
Expression, purification and identification of the FMDV
3ABC polypeptide: Production of the FMDV 3ABC
polypeptide was described previously by Chen et al. (2009)
[8].  Briefly, E. coli that was transformed with the pTH 162-
B plasmid carrying a partial 3ABC gene was cultivated.
Expression of the 3ABC polypeptide was induced by the
isopropylthiogalactoside.  Next, the transformed E. coli
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polypeptide within the lysate was purified using affinity
chromatography.  The specificity of the purified polypeptide
was confirmed using western blotting.
Mouse immunization and production of a mAb against
3ABC: One hundred milligrams of the FMDV 3ABC recom-
binant protein was subcutaneously injected into 3 five-
week-old BALB/c mice with Genesisbio (GB) pristine adju-
vant four times at four-week intervals.  Three days before
cell fusion, the mice were boosted with the same amount of
the protein diluted in phosphate-buffered saline by subcuta-
neous injection.  Spleen cells obtained from the immunized
mice were then fused with Sp2/0 myeloma cells in 1 ml of
polyethylene glycol 1500 (Roche, Mannheim, Germany).
After a two-week incubation in Hypoxanthine-Aminop-
terin-Thymidine (HAT) selection medium, the supernatant
from the fused cells was screened using western blotting and
indirect ELISAs [23] based on the recombinant protein of
O/TW/1999.  Fused cells, or hybridomas, with a positive/
negative (P/N) ratio greater than 2 in the indirect ELISA
were cloned by limiting dilution.  The positive hybridoma
(CmA 40) and 0.5 ml of GB pristine adjuvant was mixed
and injected into a BALB/c mouse.  The mAb was harvested
from the ascites of the mouse, and the isotype of the mAb
was determined using a mouse monoclonal isotyping kit
(IsoQuickTM strips, Envirologix, Portland, ME, USA)
according to the manufacturer’s instructions.
Sandwich ELISA: A sandwich ELISA for the O serotype
was established to detect serum antibodies against 3ABC
NSP.  The optimal dilution of the purified 3ABC recombi-
nant protein was determined using chessboard titrations of
mAb and antigen.  The working dilution gave an absorbance
on the upper part of the linear region of the titration curve
(between 1.5 and 2 optical density units) [6].  First, 96-well
microtiter plates (Nunc Maxisorp, Rochester, NY, U.S.A.)
were coated with the saturating dilution of mAb diluted in
0.06 M carbonate/bicarbonate buffer, pH 9.6, coating buffer
(KPL, Gaithersburg, MD, U.S.A.) and incubated overnight
at 4°C or for 1 hr at 37°C.  The 3ABC recombinant protein
in dilution buffer (PBS, pH 7.4) was added, and the plate
was incubated at 37°C for 1 hr.  Test pig serum (100 μl)
diluted 1:100 in blocking buffer [1% (w/v) casein; Hammer-
sten grade] in 100 mM sodium phosphate (150 mM NaCl,
pH 7.4, containing Kathon® antimicrobial agent) was added
to each well and incubated at 37°C for 1 hr.  Horseradish
peroxidase-labeled goat anti-swine IgG (100 µl, Santa Cruz
Biotechnology, Inc., Santa Cruz, CA, U.S.A.) diluted
1:7000 in blocking buffer was added to each well, and the
plate was incubated at 37°C for 1 hr.  The substrate solution
(3,3’,5,5’-tetramethylbenzidine, TMB; Thermo, Rockford,
IL, U.S.A.) was added, and the plate was incubated at room
temperature for 15 min.  To each well, 50 µl of 1.0 M sulfu-
ric acid stop solution (KPL, Gaithersburg, MD, U.S.A.) was
added to stop the color development.  Optical density at 450
nm (OD450) was measured using a spectrophotometer.  Each
incubation step lasted 1 hr at 37°C and was followed by
washing six times with PBS (pH 7.4).  Results were
expressed as a test to control (T/C) index.
Commercially available ELISA kits for the detection of
antibodies to FMDV NSPs: Three commercially available
ELISA kits were used in our study for comparison with our
sandwich ELISA with regard to antibody detection ability.
PrioCHECK FMDV-NS (Prionics Lelystad B.V., Lelystad,
The Netherlands) is a blocking ELISA based on the bacu-
lovirus-expressed 3ABC polypeptide [35, 36].  UBI FMD
NS EIA (Swine; United Biochemical Inc., Hauppauge, NY,
U.S.A.) is an indirect ELISA based on a synthetic 3B pep-
tide [34].  CHEKIT FMD-3ABC po (IDEXX Laboratories,
Inc., Westbrook, ME, U.S.A.) is an indirect ELISA based on
the E. coli-expressed 3ABC polyprotein [13].  The assays
were conducted according to the manufacturers’ instruc-
tions.  Agreement between ELISA kits was evaluated using
kappa statistics.
RESULTS
Isotype of the mAb: The isotype of the produced mAb was
identified as IgG1, and its light chain was a kappa chain.
Stability of the control sera in the sandwich ELISA: In
preliminary studies of analytical specificity, the optimal
dilutions of reagents were determined using checkerboard
titrations, employing known strong positive, weak positive
and negative sera.  The optimal dilution of test sera was first
established.  A dilution of 1/100 was selected as the dilution
that best discriminated positive from negative sera while
minimizing false positive or false negative results.  The limit
dilutions of strong and weak positive control sera were 1/
800 and 1/200, respectively (Fig. 1).  The stability of posi-
tive and negative control sera was evaluated with sandwich
ELISA in each of the eighteen 96-well plates.  The statistics
were calculated, and the results showed a mean ± SD of 0.90
± 0.09 for the positive control and 0.09 ± 0.02 for the nega-
tive control in the 18 plates.
Determination of the cut-off value in sandwich ELISA:
Fig. 1. Analytical specificity of the sandwich ELISA for
detecting the anti-3ABC antibody. Swine sera No. 266,
1536, 265 and 1547 were FMD-positive sera, and the
SPF serum was the serum obtained from five specific
pathogen-free pigs. The blank value was 0.05 of the
OD450.
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OD450 value of the test sera by the mean OD450 value of the
positive control sera.  A total of 287 negative swine sera
(255 from naïve pigs and 32 from zero dpi sera in the serum
panel) and 62 experimentally-infected pig sera were used to
determine the cut-off values for the sandwich ELISA.  Sera
collected from 96 SPF pigs were used to validate the speci-
ficity of the sandwich ELISA.  Most of the test results had a
value less than 0.15 at OD450 nm, and only 83.3% were
higher at OD450 0.06–0.11.  In addition, the mean OD450 nm
value of the duplicate testing sera from 165 vaccinated pigs
was less than 0.23.  The cut-off value was therefore deter-
mined to be OD450 0.23.  Samples were considered negative
when OD450 was less than or equal to 0.23 and positive when
OD450 was greater than 0.23 (Table 1).
Kinetics of the antibody response to 3ABC: A positive
serum panel of sequentially sampled swine sera was tested
using the VNT and commercial kits.  Anti-3ABC antibodies
in 32 experimentally infected pigs were first detected at 8
dpi.  All the pigs tested positive at 10 dpi.  From 10 dpi, the
positive percentage stayed over 90% throughout the period
of the animal experiment, as schematically depicted in Fig.
2a.  All experimentally infected pigs had virus neutraliza-
tion antibody titers ranging from 1:16 to 1:1,024 after 4 dpi,
confirming infection.
Comparison of the sandwich ELISA and the commer-
cially available ELISA kits: The PrioCHECK kit and UBI
kit gave similar results, but the CHEKIT kit did not.  With
the CHEKIT kit, antibodies were initially detected at 14 dpi,
and the positive percentage stayed under 80% throughout
the rest of the experiment (Fig. 2a).  Results obtained from
the sandwich ELISA were compared with those from the
PrioCHECK, UBI and CHEKIT kits.  The kappa statistics
given by the comparison were 0.95 (ELISA/PrioCHECK),
0.87 (ELISA/UBI) and 0.37 (ELISA/CHECK).  There was
97.5, 93.4 and 66.6% agreement between the results
obtained from our ELISA and those obtained from the Prio-
CHECK, UBI and CHEKIT kits, respectively.  The diagnos-
tic sensitivity of the assay was 98.4%, and the diagnostic
specificity was 100% for naïve and vaccinated pigs.  The
results obtained from our assay were similar to those of the
PrioCHECK and UBI kits; however, when testing vacci-
Table 1. Distribution of the T/C ratio profile tested using sandwich ELISA
T/C interval Naïve Vaccinateda) Experimentally Experimentally
(OD450nm) Pre-outbreaka) SPFa) noninfected infected 
(0 dpi)a) (dpi)b,c)
0–0.05 1 7 100 0 0
0.06–0.11 108 80 40 29 0
0.12–0.17 46 9 14 3 0
0.18–0.23 4 0 11 0 1
>0.23 0 0 0 0 61
Total 159 96 165 32 62
a) Cut off OD450 0.23 as negative reaction. b) Cut off OD450 0.23 as positive reaction. c) From 30
infected sera and 32 infected sera panels at 28 and 14 dpi, respectively.
Fig. 2. (a) Results of 32 positive pigs tested using the sandwich ELISA and the commercially available ELISA kits PrioCHECK
FMDV-NS, UBI FMDV NS EIA and CHEKIT FMD-3ABC po. The standardized OD450 values measured with the positive ratio
(positive pigs/total pigs, %) using the developed assay are shown. (b) The solid line indicates the standardized values measured
by the developed assay with the OD450 values. The error bar indicates the standard error of the mean at each day postinfection.
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of the UBI kit (85.3%), and when testing sera from infected
pigs, the sensitivity of our assay was better than that of the
CHEKIT kit (35.5%; Table 2).
Identification of recombinant protein to other FMDV
serotypes using bovine antiserum: All the bovine antisera,
composed of antisera against serotypes A, C, Asia 1, SAT 1,
SAT 2 and SAT 3 FMDV, gave positive results with the
optic density at 450 nm greater than 0.23 (Fig. 3).  Four out
of six antisera (serotype C, Asia 1, SAT 1 and SAT 3) had
an OD450 value above 0.5.
Specificity evaluated using antisera against SVDV and
VSV: As determined using sandwich ELISA, the six antisera
against the UKG/27/72 strain of the SVDV and the three
antisera against the New Jersey and Indiana strains of the
VSV were negative without nonspecific cross-reactions
between FMDV and SVDV.
DISCUSSION
Vaccination is one of the main methods that can be imple-
mented to control FMD, and it is currently the primary con-
trol strategy used in Taiwan.  In countries and areas where
FMD vaccination is implemented, the serological differen-
tial diagnosis of FMD can be difficult because vaccinated
animals cannot be distinguished from infected animals sim-
ply by the VNT, since neutralizing antibodies are elicited by
vaccination, natural infection or both.  Several countries that
vaccinate against FMD now use antibodies against NSP of
FMDV as replaced serological markers for identifying
FMDV-infected animals [9, 26].  Developing novel serolog-
ical methods or improving the currently available ones,
especially ELISA, is a crucial step toward the eradication of
FMD [1, 13, 25, 35].  In this study, a 3ABC NSP-based
sandwich ELISA was developed to test for the serum anti-
body against 3ABC.
In our study, the cut-off value was determined to be 0.23
of the OD450 value based on testing sera from naïve, vacci-
nated and experimentally infected pigs (Table 1).  One of
the four naïve sera collected prior to the first outbreak
showed an OD450 value of 0.18, and the other three showed
an OD450 value of 0.21.  All four sera were determined to be
negative by our sandwich ELISA and the other ELISA kits
(Table 1).  All the experimentally infected pigs at 8 dpi still
had strong positive reactions and remained positive up to 34
dpi (Fig. 2a and 2b).  These results were consistent with a
previous report in which strong NSP antibody responses
were observed by 30 dpi in experimentally infected pigs
tested by both 3B and 3ABC ELISA kits [7].  Sera sampled
from one pig at 21, 28 and 34 dpi had OD450 values of 0.17,
0.12 and 0.15, respectively, using the sandwich ELISA.  The
three sera were negative according to the PrioCHECK kit,
CHEKIT kit and our in-house chromatographic strip [8].  In
contrast, they tested positive using the UBI kit.  However,
the three sera had neutralizing antibody titers of 1:256,
1:256 and 1:64, respectively, implying that the pig was truly
infected.  The difference in results might be due to the anti-
body type used in the test procedures, such as type-specic
polyclonal versus FMD-specic monoclonal antibodies or the
difference in the specicity of reactions [32].  The inconsis-
tency might also be attributed to the conformational differ-
Table 2. Sensitivity and specificity of the sandwich ELISA and the commercially available
ELISA kits in swine
Tests Sensitivity Specificity
Infecteda) SPF Pre-outbreak Vaccinated
Sandwich ELISA 98.40% 100% 100% 100%
(61/62) (96/96) (159/159) (165/165)
PrioCHECK kit 98.40% 100% 100% 100%
(61/62) (96/96) (158/158) (167/167)
UBI kit 98.40% 100% 100% 85.30%
(61/62) (96/96) (158/158) (93/109)
CHEKIT kit 35.50% 100% 100% 100%
(22/62) (96/96) (158/158) (167/167)
a) The sensitivity was calculated at 14 DPI from 32 infected sera panels and 30 infection pig sera.
Fig. 3. Detection of the NSP antibody in bovine sera
using the sandwich ELISA. The tested sera were
obtained from cattle infected with the FMDV of sero-
types A, C, Asia 1, SAT 1, SAT 2 and SAT 3. Fetal calf
serum (FCS) and normal bovine serum were used for
negative controls. Only PBS (pH 7.4) buffer was added
to the blank.
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expression systems [9].
Comparison of the performance for the detection of 320
experimentally infected pig sera between the sandwich
ELISA and the PrioCHECK, UBI and CHEKIT kits demon-
strated kappa statistics of 0.95, 0.87 and 0.37, respectively,
demonstrating a high level of agreement between the results
obtained from the sandwich ELISA and those from the Prio-
CHECK and UBI kits.  Our assay could be carried out
within a single day or 4–5 hr, which is shorter than the time
required for the PrioCHECK kit, which needs an overnight
incubation of samples.  In addition, when testing vaccinated
pigs, the specificity of our assay was better than that of the
UBI kit (85.3%; Table 2).  The results showed that the CHE-
KIT kit had a high specificity of 100%, which is similar to
the specificity reported elsewhere [24].
Our study revealed a difference in the diagnostic sensitiv-
ity among the developed sandwich ELISA, CHEKIT kit and
3ABC-based indirect ELISA.  The sensitivity of the sand-
wich ELISA was higher than that of the CHEKIT kit.  We
believe the higher sensitivity of our assay may result from
the strong and specific binding of the FMDV-NSP recombi-
nant protein to the monoclonal antibody used.
The analytical sensitivity was established by the detection
of NSP antibody.  The chromatographic test strip and sand-
wich ELISA could detect the positive sera that were diluted
10–5 and 10–2 fold, respectively.  The analytical sensitivities
of the two tests were 10,000 and 10 times higher than that of
the commercial PrioCHECK ELISA (diluted 10–1 fold),
respectively.  This revealed that the chromatographic test
strip could rapidly accomplish the detection of NSP antibod-
ies and was more suitable than the ELISAs when applied to
clinical diagnosis.  However, the ELISAs could detect a
larger number of samples at a time in a laboratory when
used by skilled personnel.  Furthermore, the analytical sen-
sitivity of the sandwich ELISA was slightly more sensitive
than the commercial PrioCHECK ELISA.  Consequently,
the sandwich ELISA could be used for the detection of NSP
antibodies in vaccinated animals that have been infected by
FMD virus and maybe become carriers.  Because the protec-
tion provided by the vaccine-induced antibodies might limit
the replication of FMDV and result in presentation of a very
low level of NSP antibodies in vaccinated animals, the
detection of NSP antibodies needs a higher sensitivity test
than is available currently [10].  The pig has not been con-
sidered a carrier animal of FMDV.  The levels of NSP anti-
body detected by the UBI and PrioCHECK kits in infected
pigs were gradually decreasing and may become negative
after 60 to 180 dpi [7].  However, 15 infected sera collected
from pigs that received one dose of FMD vaccine at 12
weeks old and were infected with 105 TCID50 O/TW/97
FMDV at 31 weeks old.  All of the 15 vaccinated pigs
showed typical vesicle lesions on the feet and snout at 4
days postchallenge.  All 15 sera were NSP antibody posi-
tive, as detected by the chromatographic strip.  However, 11
out of the 15 sera were positive by the sandwich ELISA.  In
contrast, only 9 of the 15 sera were positive by the Prio-
CHECK ELISA.  The results indicated that the former two
methods were more sensitive than the latter one.  However,
these methods should be applied to the detection of NSP
antibody for subclinical infected animals in the future.
This paper described a sandwich ELISA for the detection
of serum antibodies to the 3ABC NSP of the FMDV sero-
type O.  To evaluate the potential ability of the test to detect
anti-NSP antibodies elicited by FMDVs of other serotypes,
bovine sera from cattle infected with serotypes other than
serotype O were also tested using our method.  The results
suggested that our sandwich ELISA was effective in detect-
ing the NSP antibodies against other FMD serotypes in
swine (Fig. 3).
For biosafety consideration, the 3ABC NSP of FMDV
was used as an immunogen instead of the inactivated virus
in the production of mAb.  The results showed that our sand-
wich ELISA using the 3ABC and anti-3ABC antibody
derived from the FMDV O/TW/99 strain could detect anti-
bodies induced by both the O/TW/99 and O/TW/97 strains
in swine antisera (data not shown).
In this study, we found that using the expressed proteins
to immunize BALB/c mice was a safer strategy to prepare
mAb, since this lowered the risk of live virus escaping from
the laboratory [13, 17].  To enhance safety and efficacy, we
designed our sandwich ELISA using expressed protein
instead of live FMDV as a coated antigen.  Therefore, this
assay may be safely performed in laboratories with basic
biosafety requirements.
In addition, the purpose of the assay was to detect anti-
NSP antibodies so as to identify previously infected animals
in populations.  As discovered through our experiments, the
sandwich ELISA demonstrated satisfactory sensitivity and
specificity, both higher than 95%.  The method was able to
distinguish antibodies produced by naturally infected ani-
mals from those produced by vaccinated animals.  Further-
more, with antisera against SVDV and VSV, the assay
proved that it could specifically recognize antibodies
against FMDV, but not cross-react with antibodies against
SVDV and VSV, indicating that it can be used in areas
where the three diseases might be present.
Employment of mAb in our sandwich ELISA improved
the specificity.  Our study revealed that the performance of
sandwich ELISA was unsatisfactory, either in terms of low
specificity when testing vaccinated pigs by the UBI kit or in
terms of low sensitivity when testing infected pigs by the
CHEKIT kit (Table 2).  To minimize these drawbacks, a
3ABC-specific mAb was introduced to capture the coated
antigen.  Introduction resulted in a satisfactory specificity
without losing diagnostic sensitivity.
To sum up, the sandwich ELISA described in the present
article had the advantages of convenience, stability, high
sensitivity, high specificity, safety, and high throughput.
With a reliable immunoassay system, we hope to be able to
diagnose vesicular diseases in swine more effectively,
thereby further improving veterinary disease control and the
culling of infected animals in the early stages.
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